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A balance of activating and inhibitory signals, 
mediated through distinct classes of receptors 
found on their surface, regulates NK cell activ-
ity (Ortaldo and Young, 2005; Lanier, 2008). 
Activating signals are interrupted when inhibi-
tory receptors on NK cells engage MHC class I 
(MHC I) molecules on target cells. This dual 
receptor system, also known as the “missing 
self” activation mechanism (Kärre et al., 1986), 
enables NK cells to detect virally infected cells 
that exhibit a reduced expression of MHC I 
molecules. To compromise antigen presenta-
tion in the context of MHC I molecules, and 
thus evade the attack by CD8+ T cells, cyto-
megaloviruses (CMVs) encode immunoeva-
sion proteins that can downmodulate the 
expression of MHC I on the cell surface (Hengel 
et al., 1999), most likely by a recently described 
mechanism demonstrating that the down-
regulation of MHC I from the surface of in-
fected cell is a result of a MHC I turnover and 
inhibited supply of newly synthesized mole-
cules, rather than the active downmodulation 
of the surface-resident portion (Lemmermann 
et al., 2010). However, this lowers inhibitory 
interactions and triggering through inhibitory 
Ly49 receptors, and might activate NK cells 
through a missing self–dependent mechanism. 
In addition, CMVs actively compromise NK 
cell activation using other strategies, such as the 
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Cytomegaloviruses (CMVs) are renowned for interfering with the immune system of their 
hosts. To sidestep antigen presentation and destruction by CD8+ T cells, these viruses reduce 
expression of major histocompatibility complex class I (MHC I) molecules. However, this 
process sensitizes the virus-infected cells to natural killer (NK) cell–mediated killing via the 
“missing self” axis. Mouse cytomegalovirus (MCMV) uses m152 and m06 encoded proteins 
to inhibit surface expression of MHC I molecules. In addition, it encodes another protein, 
m04, which forms complexes with MHC I and escorts them to the cell surface. This mecha-
nism is believed to prevent NK cell activation and killing by restoring the “self” signature 
and allowing the engagement of inhibitory Ly49 receptors on NK cells. Here we show  
that MCMV lacking m04 was attenuated in an NK cell– and MHC I–dependent manner.  
NK cell–mediated control of the infection was dependent on the presence of NK cell  
subsets expressing different inhibitory Ly49 receptors. In addition to providing evidence  
for immunoevasion strategies used by CMVs to avoid NK cell control via the missing-self 
pathway, our study is the first to demonstrate that missing self–dependent NK cell activa-
tion is biologically relevant in the protection against viral infection in vivo.
© 2010 Babic et al. This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommer-
cial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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should attenuate MCMV in an NK cell–dependent manner 
by decreasing the expression of ligands for inhibitory NK cell 
receptors. To test this, we infected BALB/c mice with either 
WT MCMV or virus lacking m04 (m04). A portion of mice 
in each group was depleted of NK cells, and the virus titer in 
the spleen was determined 3 d post infection (dpi). We have 
observed a significantly lower viral replication of the m04 
mutant, which was reverted to WT MCMV titer after deple-
tion of NK cells (Fig. 1 A). These results clearly support the 
initial hypothesis that m04/gp34 causes NK cell inhibition. 
We have also tested whether this phenotype is dependent on 
the expression of MHC I molecules. The aforementioned 
difference in viral titers between m04 and WT MCMV was 
absent in TAP1-deficient mice (Tap1/) and mice deficient 
for 2 microglobulin (2m/), both on BALB/c back-
ground (Fig. 1 B).
Moreover, we have tested the impact of m04 in several 
other mouse strains (Fig. 1 C). Even more pronounced than 
in BALB/c mice, the absence of m04 resulted in an NK cell–
dependent viral attenuation in C3H/J (H-2k), CBA/J (H-2k), 
BALB.K (H-2k), and B10.M x BALB/c (BALB.F; H-2f) 
mouse strains. However, in C57BL/6 (H-2b) mice no differ-
ence in viral titers was observed between m04 and WT 
MCMV (Fig. 1 D). To avoid a strong activation of C57BL/6 
NK cells through the Ly49H receptor, which can abolish the 
impact of m04, we have used BALB.B mice, of the identical 
H-2 haplotype but different NKC background. As expected, 
without Ly49H, BALB.B mice showed a high virus titer; 
however, no attenuation with m04 observed (Fig. 1 D). 
Therefore, we concluded that the attenuation of m04 mu-
tant is NK cell– and MHC I–dependent. This phenomenon 
is clearly seen in mice of the H-2k and, to a lesser extent, the 
H-2d backgrounds, but is most likely completely absent in 
H-2b animals.
MCMV m04 protects infected cells from NK cell– 
mediated killing
To further elaborate the role of m04 in protecting infected 
cell from NK cell–mediated recognition, we have tested 
ex vivo the ability of splenic cells from naive BALB/c and 
C3H/J mice to lyse B12 (SV40-transformed BALB/c fibro-
blasts; H-2d) and SVEC4-10 (C3H/J-derived SV40 trans-
formed endothelial cells; H-2k) cells, infected with WT or 
m04 MCMV or left uninfected. WT infected B12 and 
SVEC4-10 cells were both lysed less efficiently as compared 
with noninfected targets. However, m04-infected targets 
were more susceptible to NK cell lysis than WT-infected 
cells (Fig. 2 A).
Although it is difficult to determine if viral titers in the 
spleen are always correlated with the ex vivo function of NK 
cells, it has to be pointed out that the contribution of m04 to 
the concealment of infected cells in vitro is much less pro-
nounced. Even though in vivo MCMV can infect many dif-
ferent cell types, the antiviral activity of NK cells differs 
depending on the affected organ or tissue. Therefore, it is not 
completely unexpected that the extent of cytolytic susceptibility 
downmodulation of cellular ligands for activating NK cell 
receptors (e.g., NKG2D) or miRNAs (Jonjić et al., 2008). Be-
cause of an efficient and redundant viral immunoevasion from 
NK cells, most laboratory mouse strains, as well as feral mice, 
fail to mount a significant NK cell response toward mouse 
CMV (MCMV; Scalzo et al., 2005), with the exception of a 
few mouse strains that possess an activating Ly49 receptor, 
which specifically recognizes infected cells and therefore cir-
cumvents viral immunoevasion (Arase et al., 2002; Smith et al., 
2002; Adam et al., 2006; Kielczewska et al., 2009).
The aim of this study was to explain the mechanisms by 
which MCMV avoids NK cell control, in spite of the down-
regulation of MHC I molecules on the surface of infected 
cells. As shown previously, MCMV encodes three proteins 
involved in the regulation of MHC I expression (Wagner 
et al., 2002; Holtappels et al., 2006; Pinto et al., 2006). The 
m152-encoded gp40 glycoprotein arrests MHC I at the level 
of the ERGIC/cis-Golgi compartment (Ziegler et al., 1997), 
whereas m06-encoded gp48 redirects MHC I complexes to 
lysosomes for degradation (Reusch et al., 1999). The third 
MCMV regulator of MHC I expression is gp34, encoded by 
the m04 gene (Kleijnen et al., 1997). Unlike the other two, 
m04/gp34 does not prevent the surface expression of MHC I, 
but instead binds to these proteins in the ER, forming com-
plexes that can reach the cell surface (Kleijnen et al., 1997). 
Although it has been proposed that m04/gp34 cooperates with 
two other immunoevasins to compromise antigen presentation 
to CD8+ T cells (Kavanagh et al., 2001a), recently published 
data indicate that m04 is not a CD8+ T cell immunoevasin on 
its own, but rather an antagonist of m152 function (Holtappels 
et al., 2006; Pinto et al., 2006). It has been suggested that m04/
gp34 might inhibit NK cell activation through its ability to es-
cort MHC I to the cell surface to engage inhibitory NK cell 
receptors (Kleijnen et al., 1997). We have recently shown that 
m04/gp34 is essential for the recognition of infected cells by 
the activating Ly49P receptor, which recognizes H-2Dk to-
gether with m04 product and another, thus far unidentified 
viral component (Kielczewska et al., 2009).
Here, we provide evidence that MCMV lacking the m04 
gene (m04) is attenuated in an NK cell– and MHC I– 
dependent manner in several mouse strains. By using reporter 
cells expressing the inhibitory receptor Ly49A, we have 
shown that the expression of m04 in infected cells allows the 
engagement of this receptor by enabling MHC I molecules 
to reach the cell surface, despite the two viral MHC I inhibi-
tors. Our studies provide the first evidence that NK cell rec-
ognition of the missing self is relevant in the recognition and 
control of a viral pathogen in vivo.
RESULTS
m04 MCMV is attenuated in vivo in an NK cell–  
and MHC I–dependent manner
Based on the ability of m04 to escort MHC I molecules to 
the surface of infected cells, we have hypothesized that its 
primary function is blocking NK cell activation via the miss-
ing self mechanism. If this is correct, the deletion of m04 
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m04 rescues the engagement  
of inhibitory Ly49 receptors
Because m04-modified H-2Dk has 
been shown to interact with the acti-
vating Ly49P receptor (Desrosiers 
et al., 2005; Kielczewska et al., 2009), 
on the basis of our findings, we have hy-
pothesized that m04-modified MHC I 
can associate with the inhibitory Ly49 
receptors as well. Ly49A is a strong 
inhibitory receptor that recognizes 
H-2Dd, H-2Dk, and H-2Dp (Chung 
et al., 2000). It can be found in most 
NK haplotypes (including BALB/c, 
CBA/J, and C57BL/6) and is ex-
pressed on 5–20% of NK cells (Ortaldo et al., 1999; Chung 
et al., 2000). The ligand-binding domain of Ly49A is closely 
related to that of Ly49P (94% amino acid sequence homol-
ogy; Makrigiannis et al., 2005); therefore, Ly49A seemed 
to be an obvious candidate to test our hypothesis.
We constructed a reporter cell line expressing the ecto-
domain of Ly49A isolated from the BALB/c strain fused to 
the CD3 intracellular domain (Ly49ACD3). Co-culture of 
Ly49ACD3 reporter cells with uninfected primary mouse em-
bryonic fibroblasts (MEFs) derived from H-2k background 
(CBA/J mice) resulted in the activation of reporter cells 
(Fig. 3 A, middle). Next, we infected MEFs with WT 
MCMV and co-cultured them with Ly49ACD3 reporter cells. 
Surprisingly, despite a dramatic down-regulation of MHC I 
molecules from the surface of infected cells as early as 8 h post 
infection (hpi; Fig. 4 B and unpublished data), Ly49ACD3 
carrying reporter cells were activated to a similar extent as 
when co-cultured with uninfected cells. Moreover, we ob-
served an increase in GFP fluorescence intensity of the re-
porter cells, indicating that the same percentage of reporter 
cells was activated, but with even greater signal strength 
(Fig. 3 A). Furthermore, when reporter cells were co- 
cultured with m04-infected cells, the activation of Ly49A 
reporter cells was dramatically reduced or even abolished 
(Fig. 3 A). This activation was H-2 dependent because 
Ly49ACD3 reporters co-cultured with H-2d targets showed a 
of certain cell lines does not directly correlate with NK cell 
efficacy in vivo.
Because both B12 and SVEC4-10 target cells constitu-
tively express NKG2D ligands (Fig. 2 B), uninfected cells 
are likely lysed by NK cells via an NKG2D-dependent 
mechanism, but the role of other activating receptors can-
not be excluded. It is notable that MCMV down-regulates 
ligands for NKG2D receptor on these cells, with the ex-
ception of surface-resident RAE-1 in SVEC4-10 cells, 
which is constitutively resistant to MCMV (Arapovic et al., 
2009). Because m04 does not interfere with the expression 
of these ligands (Fig. 2 B), the decrease in NK cell lysis of 
WT MCMV–infected cells as compared with uninfected 
targets might be caused by a decreased signal from an acti-
vating receptor (e.g., NKG2D) and/or NK cell inhibition 
provided by m04–MHC I complexes. Regardless, in the 
absence of m04, MCMV infected cells regain susceptibility 
to NK killing. Together with in vivo results, this finding 
confirms the inhibitory role of m04 in NK cell–mediated 
virus control.
We have also performed the same assay on the macro-
phage cell line RAW264.7 derived from BALB/c mice. 
Contrary to B12 and SVEC4-10 cells, WT MCMV–infected 
RAW264.7 cells were lysed to a greater extent than nonin-
fected targets, whereas m04-infected targets were again more 
susceptible to lysis than WT-infected cells (Fig. S1).
Figure 1. m04 is attenuated in vivo  
in an NK cell– and MHC I–dependent 
manner. (A–D) Indicated strains of mice were 
injected i.v. with 2 × 105 PFU (except C57BL/6, 
which received a dose of 3 × 105 PFU) of WT 
or m04 MCMV and 3 dpi viral titers in 
spleens were assessed. Where indicated, mice 
were depleted of NK cells by injection of 20 µl 
of anti-AGM1. P values, unpaired two-tailed 
Mann-Whitney test. A circle depicts the titer 
for each individual mouse; a small horizontal 
line indicates the mean. Data are representa-
tive of at least two independent experiments 
with four to five mice per group.
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assumption, we constructed a reporter 
cell line expressing the Ly49A ectodo-
main fused to the stalk, transmem-
brane, and cytoplasmic domains of 
Ly49H, which associates with DAP12 
adaptor protein containing one ITAM 
motif (Ly49AHCTS) contrary to Ly49A-
CD3 chimera (Ly49ACD3), which 
by itself encodes three ITAM motifs. 
This Ly49AHCTS chimeric receptor shows less binding to 
MHC I molecules and generates a weaker signal (Ito et al., 
2009). Therefore, Ly49AHCTS reporter cells were poorly acti-
vated by uninfected or m04 MCMV-infected cells (of H-2k 
or H-2d haplotype), but were still strongly activated when 
co-cultured with WT MCMV-infected cells (Fig. 3 B). Sim-
ilar results were obtained with reporter cells expressing the 
Ly49A allele from C57BL/6 mice (Fig. 3 B), which also 
indicated that the lack of interaction between Ly49A and 
MHC I in C57BL/6 mice is determined by MHC I and not 
by the Ly49A allele. Therefore, we concluded that m04–MHC I 
complex might have a higher affinity for Ly49A as compared 
with native MHC I.
To assess whether the effect of m04 is restricted to 
Ly49A, we generated 2B4 NFAT-GFP reporter cells ex-
pressing Ly49C. Ly49C is another inhibitory receptor with 
high affinity for H-2Kb, H-2Db, H-2Kd, H-2Dd, and 
H-2Dk; Ly49C is found in most NK haplotypes (including 
BALB/c, CBA/J, and C57BL/6; Brennan et al., 1996a). 
However, whereas Ly49A is present on 5–10% of NK 
cells, Ly49C is expressed on 50% of NK cells in BALB/c 
mice. Co-culturing these reporter cells with target cells in-
fected with WT or uninfected cells of H-2b, H-2d, or H-2k 
origin, we observed high activation of Ly49C reporter 
cells (Fig. 3 C, left, and not depicted). An only slightly 
lower activation of Ly49C reporter cells was observed upon 
decreased stimulatory potential and therefore a less dramatic 
impact of m04 absence, which is in agreement with the 
results obtained in vivo (Fig. 3 A, middle). As a control, 
Ly49P-expressing reporter cells were not activated after co-
culture with uninfected or m04-infected cells (Fig. 3 A, left), 
which further supports our previous results (Kielczewska 
et al., 2009).
Because m04 was not attenuated in C57BL/6 or in 
BALB.B mice, we tested the ability of H-2b cells, either in-
fected or uninfected, to engage the Ly49A receptor. As shown 
in Fig. 3 A (right), in contrast to Ly49ACD3 reporter cells co-
cultured with CBA/J or BALB/c MEFs, MEFs derived from 
C57BL/6 mice failed to activate reporter cells, confirming 
that Ly49A does not bind to MHC I molecules of the H-2b 
haplotype (Karlhofer et al., 1992), and again supporting our 
in vivo finding. Consequently, the infection of C57BL/6 
cells with either WT or m04 MCMV did not result in the 
activation of Ly49ACD3 reporter cells. Altogether, these find-
ings demonstrate that m04 plays an essential role in prevent-
ing NK cell activation via the missing self mechanism by 
providing ligands for inhibitory NK cell receptors, at least in 
the context of H-2d and H-2k haplotype.
A consistent increase in GFP expression by Ly49A re-
porter cells co-cultured with WT MCMV-infected cells 
made us conclude that association of m04/gp34 with MHC I 
molecules increases their binding to Ly49A. To test this 
Figure 2. m04 protects cells from NK 
cell–mediated killing. (A) Target B12 and 
SVEC4-10 cells were CFSE-labeled, infected 
with WT or m04 MCMV for 10 h, or were left 
uninfected, and co-cultured with splenocytes 
from naive BALB/c or C3H/J mice, respectively. 
Specific lysis of target cells was assessed by 
staining with 7-AAD and analyzed by flow 
cytometry. Data points on the graph represent 
the mean of a triplicate for each sample. Error 
bars represent SD. Data are representative of 
five (SVEC4-10) or three (B12) independent 
experiments. Statistical significance applies 
for the effector-to-target ratio of 16:1 and is 
indicated by asterisks. *, P < 0.05; **, P < 
0.001; ***, P < 0.0001. (B) B12 and SVEC4-10 
cells were infected with WT or m04 MCMV 
or left uninfected. Cells were harvested 10 hpi 
and stained for surface MHC I and NKG2D 
ligand expression. Data are representative of 
two independent experiments.
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co-culture with m04-infected BALB/c MEFs when com-
pared with WT-infected targets (Fig. 3 C, left). However, co- 
culture of Ly49C reporter cells with MEFs of H-2f origin 
showed significantly lower activation of the Ly49C reporter 
cells co-cultured with m04-infected targets (Fig. 3 C, 
right). Thus, although the effect of m04 is most evident 
with Ly49A reporter cells, it is also visible with Ly49C re-
porter cells.
m04 antagonizes the function of m152  
in the downmodulation of H-2Dk
To study the efficiency of the m04 gene product in the 
context of MCMV infection, we investigated the role of 
m04 alone, or in relation to two other MCMV MHC I 
regulators and used viral mutants individually lacking m04, 
m06, or m152, and different combinations of these three 
genes, or a triple mutant (Wagner et al., 2002). Contrary 
to the deletion of m04, which strongly reduced the activa-
tion of Ly49A reporter cells in the case of WT infection, 
the deletion of either m06 or m152 immunoevasins did not 
affect the capacity of infected cells to activate the reporter 
cell line (Fig. 4 A, bottom). As expected, the deletion of 
m06 and m152 together (m06m152), or the deletion of 
all three viral regulators of MHC I (m04m06m152) 
resulted in Ly49A reporter cell activation (Fig. 4 A, top). 
When the deletion of m04 was combined with a deletion 
of m06 (m04m06), the reporter cell activation was also 
lost, indicating that m152 alone is sufficient to down-regulate 
MHC I expression and prevent Ly49A engagement, when 
unopposed by m04. However, when both m04 and m152  
were missing (m04m152), Ly49A reporter cells were acti-
vated to the same extent as the reporter cells co-cultured 
with noninfected cells. To elucidate this somewhat unexpected 
finding we followed the kinetics of surface H-2Dk down-
regulation in cells infected with WT MCMV or mutants 
lacking m06, m04 alone, or in combination with the dele-
tion of m06 or m152 genes (Fig. 4 B). We have observed 
differences in the kinetics of H-2Dk surface downmodula-
tion, showing a more rapid and efficient activity of m152 
(infection with m04m06) in comparison to m06 (infec-
tion with m04m152). In addition, these results confirm 
the previous findings of Holtappels et al. (2006), which 
showed that m04 antagonizes the MHC I retention func-
tion of m152 (as seen upon infection with m06). Only at 
36 hpi does m06 induce levels of H-2Dk down-regulation 
comparable to those of m152. Therefore, given the results 
shown in Fig. 4 A, the absence of m04 in the case of 
m04m152 MCMV infection did not prevent Ly49A 
binding because of the differential kinetics of MHC I down-
regulation by m06 and m152.
Figure 3. m04 allows engagement of inhibitory Ly49 receptor.  
(A) Ly49ACD3 or Ly49PCD3 NFAT-GFP reporter cells were co-cultured with 
CBA/J, BALB/c, or C57BL/6 MEFs and either infected with indicated viruses 
or left uninfected. GFP expression was assessed (in the case of infected 
cells, overlay was made with uninfected cells presented by open histo-
grams). Data are representative of two to four independent experiments. 
(B) Ly49AHCTS reporter cells were co-cultured with the indicated MEF cells, 
left uninfected, or infected with WT or m04 MCMV. GFP expression was 
assessed. Data are representative of two to four independent experiments. 
(C) Ly49C NFAT-GFP reporter cells were co-cultured with BALB/c MEFs and 
BALB.F MEFs that were infected with indicated viruses or left uninfected 
and GFP expression was assessed. P values, unpaired two-tailed  
Student’s t test. Data are means of four independent experiments. Error 
bars represent SD.
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Ly49C+ and Ly49A+ NK cells results 
in a moderate control of m04 MCMV, 
whereas the Ly49G2+ NK cell deple-
tion results in a loss of control of 
the mutant virus. This suggests that 
Ly49G2+ NK cells play a dominant 
role in the control of m04 MCMV 
replication.
The presence of m04 impairs  
the proliferation of NK cells
To test whether the enhanced control 
of m04 MCMV infection as opposed 
to WT MCMV infection is accompa-
nied by increased proliferation and/or 
alterations in the size of NK cell sub-
populations, we have infected BALB/c 
and BALB.K mice with WT and m04 
MCMV and monitored the prolif-
eration of total NK cells by BrdU 
incorporation at 3 dpi. There was an 
enhanced incorporation of BrdU by 
NK cells upon infection with both vi-
ruses as opposed to uninfected controls. However, NK cell 
proliferation was impaired in both mouse strains after WT 
infection as compared with mice infected with m04 MCMV 
(Fig. 5 B). Therefore, we have concluded that the presence 
of m04 impairs the proliferation of NK cells, and this impair-
ment is correlated with poor control of WT MCMV com-
pared with the virus lacking the m04 gene (m04; Fig. 1). 
Again, the impact of m04 is more pronounced in BALB.K 
than in BALB/c mice, which corresponds to the more 
pronounced differences in viral titers between WT and 
m04 observed in these mouse strains. No major differ-
ences in the proportion of various NK cell subpopulations 
expressing different inhibitory Ly49 receptors was observed 
Differential contribution of NK cell subsets expressing 
various combinations of inhibitory Ly49 receptors in control 
of m04 MCMV in vivo
We hypothesized that a lack of NK cell–dependent control 
of WT MCMV in some mouse strains could be, for the most 
part, the consequence of a strong inhibition imposed by m04 
via inhibitory Ly49 receptors. To assess the contribution of 
individual NK cell subsets expressing inhibitory Ly49 recep-
tors we depleted NK cells expressing Ly49A, Ly49C, or 
Ly49G2 in BALB/c mice and infected them with either WT 
or m04 MCMV. The results show that each of the sub-
sets contributes in part to a control of m04 MCMV, al-
though to a different extent (Fig. 5 A, right). Depletion of 
Figure 4. m04 antagonizes the function 
of m152 in the downmodulation of  
H-2Dk. (A) Ly49A NFAT-GFP reporter cells 
were co-cultured with CBA/J MEFs that were 
infected with indicated viruses or left unin-
fected, and GFP expression was assessed 
(shaded histograms, infected; open histo-
grams, uninfected). Data are representative of 
three independent experiments. (B) CBA/J 
MEFs were infected with indicated viruses or 
uninfected. Cells were harvested at the indi-
cated time points (hpi, hours post infection) 
and stained for H-2Dk expression (shaded 
histograms). Irrelevant isotype matched anti-
body was used as a control (open histogram). 
Shaded box represents the time window of 
cocultivation of target cells with reporter cells 
(experiment shown in A). Data are representa-
tive of three independent experiments.
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m04 mutant (Fig. 6). In contrast to WT 
MCMV, blocking of NKG2D in H-2d or 
H-2k mice infected with m04 MCMV 
resulted in a significant increase in virus 
titer. This suggests that lowered inhibition 
leads to NK cell activation via stimulatory 
receptors capable of recognizing ligands ex-
pressed on infected cells.
We have not observed an effect of NKG2D blocking 
after infection with WT MCMV. This might be explained 
not only by NKG2D subversion mechanisms developed by 
MCMV, but also by a strong integration of inhibitory signals 
provided by m04–MHC I–mediated ligation of Ly49 recep-
tors. Because m04 is not involved in the down-regulation of 
NKG2D ligands, one might wonder how NKG2D-blocking 
results in increased virus titers in m04 but not in WT 
MCMV–infected mice. We speculate that down-regulation 
of NKG2D ligands within different cell types in vivo is not as 
absolute as in permissively infected cells in vitro. To assess a 
possible contribution of another activating receptor, we per-
formed a similar experiment in Ncr1/ BALB/c mice (Gazit 
et al., 2006), but the results were comparable to the ones de-
scribed in normal BALB/c mice. This indicated that NKp46 
activating receptor does not participate in the missing self–
mediated recognition of MCMV-infected cells (unpub-
lished data).
between WT and m04 MCMV infection, suggesting 
that all three NK cell subsets contribute to overall in-
creased NK cell proliferation after infection with m04 
virus (Fig. 5 C). Indeed, this was visible after assessing 
BrdU incorporation by NK cell subpopulations expressing 
individual Ly49 inhibitory receptors (Fig. 5 D), both in 
BALB/c and BALB.K mice, although it was more pro-
nounced in BALB.K mice.
The control of the virus lacking m04 is partially  
mediated via NKG2D
NK cells require an activating signal to respond to an insult, 
despite the absence of MHC I–mediated inhibitory signals. 
BALB/c mice do not possess an MCMV-specific, highly ex-
pressed, and strong activating receptor, such as Ly49H, which 
is present in C57BL/6 mice. Therefore, we tested whether 
NKG2D might play a role in the missing self-mediated rec-
ognition in mice infected with either WT MCMV or the 
Figure 5. NK cells expressing inhibitory Ly49 
receptors control m04 MCMV in vivo. (A) BALB/c 
mice were i.v. injected with 2 × 105 PFU of WT or 
m04 MCMV and 3 dpi viral loads in spleen were 
assessed. Where indicated, mice were depleted of the 
indicated NK cell subsets by injecting 150 µg of the 
corresponding antibody. Mice in the control group 
received equivalent amount of PBS. P values, un-
paired two-tailed Mann-Whitney test. A circle depicts 
the titer for each individual mouse; the horizontal 
line indicates the mean. Data are representative of 
two independent experiments with five mice per 
group. (B) BrdU incorporation by total NK cells in 
BALB/c and BALB.K mice that were left uninfected or 
infected with WT or m04 MCMV was assessed 2.5 d 
after infection. P values, unpaired two-tailed Stu-
dent’s t test. Error bars represent SD. Data are means 
of three independent experiments with three mice 
per infection. (C) Proportions of CD3NKp46+ cells 
expressing Ly49A, Ly49C, or Ly49G2 in BALB/c mice 
that were left uninfected or infected with WT or 
m04 MCMV were determined 2.5 dpi by flow  
cytometry. Data are means of two independent ex-
periments. Error bars represent SD. (D) BrdU incorpo-
ration by CD3NKp46+ cells expressing indicated 
Ly49 proteins in BALB/c and BALB.K mice infected 
with either WT or m04 MCMV was assessed 2.5 dpi. 
P values, unpaired two-tailed Student’s t test. Error 
bars represent SD. Data are representative of one 
(BALB.K) or two (BALB/c) experiments with three  
mice per infection.
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In this study, we have described a mechanism by which 
MCMV evades NK cell–mediated control in spite of a marked 
down-regulation of MHC I proteins. By enabling MHC I 
molecules to escape complete down-regulation from the sur-
face of infected cells, the m04 protein allows engagement of 
inhibitory Ly49 receptors, thereby preventing NK cell activa-
tion via the missing self process. Therefore, m04 might be a 
key player in determining the threshold level of NK cell inhi-
bition. Our present findings are in accordance with recent 
studies demonstrating that the expression of inhibitory Ly49 
receptors recognizing self-MHC I ligands restrict the prolifera-
tion and effector functions of Ly49H+ NK cells in response to 
MCMV infection in C57BL/6 mice (Orr et al., 2010).
The results obtained after NK cell subset depletion indi-
cate the importance of a missing self recognition of virally in-
fected cells by each of the NK cell subsets examined, although 
the stochastic expression of inhibitory Ly49 receptors pre-
cludes the exclusive depletion of one specific subset. We ob-
served a loss of control of m04 MCMV replication in the 
absence of Ly49G2+ NK cells in BALB/c mice. The involve-
ment of Ly49G2+ NK cells has been previously described to 
be important in the control of WT MCMV in C57L.M-H2k 
mice (Xie et al., 2009). The fact that Ly49G2+ NK cell– 
depleted mice infected with WT or m04 MCMV demon-
strated increased viral titers could indicate that Ly49G2+ NK 
cells might be more easily triggered during infection and 
contribute to the control of viral spread. Indeed, previous 
work has demonstrated that Ly49G2+ NK cells preferentially 
express high-levels of IL12R2 subunit, which may render 
them more responsive to IL-12 during infection (Chakir et al., 
2000). However, we have not observed significant differ-
ences in the percentage of IFN-+ NK cells expressing differ-
ent inhibitory Ly49 receptors during WT MCMV infection 
(unpublished data). Furthermore, it has been shown that 
Ly49G2+ NK cells expand not only during MCMV infection 
but also during LCMV, mouse hepatitis virus, and vaccinia 
virus infection of C57BL/6 mice (Tay et al., 1999; Daniels 
et al., 2001). All these viruses modulate MHC I expression 
(Brutkiewicz et al., 1992; Hewitt et al., 2002; Sevilla et al., 
2004; Hahm et al., 2005; Dasgupta et al., 2007). Moreover, 
Ly49G2 lacks a ligand in mice bearing H-2b where we detect 
no attenuation in m04 viral load. More recently, it was 
shown that the interaction between Ly49G2 and H-2Dk me-
diates resistance to MCMV in H-2Dk transgenic mice other-
wise sensitive to MCMV infection (Xie et al., 2010). Our 
results show that in mice expressing H-2k where Ly49G2 rec-
ognizes only H-2Dk (Silver et al., 2002), absence of m04 re-
sults in low MHC I expression, reduced inhibitory signals, and 
a significant decrease in viral load. On the other hand, in mice 
expressing H-2d, Ly49G2 is able to interact with both H-2Ld 
and H-2Dd (Silver et al., 2002); thus, even though MHC I 
expression is low during m04 infection, the inhibitory signal 
is transmitted, resulting in attenuation in viral load in vivo.
Ly49A+ NK cells represent a minor population of NK 
cells (5% in BALB/c mice; Ortaldo et al., 1999), and 
although they are able to detect the missing self, they only 
DISCUSSION
To avoid destruction by MHC I–restricted CD8+ T cells, 
many viruses have evolved mechanisms to modulate MHC I 
expression. However, infected cells down-regulating MHC I 
should be immediately recognized by NK cells because of the 
absence of inhibitory receptor engagement (e.g., Ly49s, KIRs, 
or CD94/NKG2A), thus shifting a balance of signals toward 
NK cell activation. MCMV encodes three regulators of MHC I 
expression. Although the function of m152 and m06 as nega-
tive regulators of MHC I expression is clear, the role of m04 
remains enigmatic. Kleijnen et al. (1997) showed that m04 
biochemically antagonizes the MHC I retention function of 
m152, a finding confirmed functionally in subsequent studies 
(Wagner et al., 2002; Holtappels et al., 2006), thus showing 
m04 as a positive regulator of MHC I cell surface expression 
and antigenic peptide presentation. However, it has also been 
proposed that the binding of m04 to MHC I proteins might 
interfere with the peptide loading onto MHC I or with the 
recognition by the TCR (Kavanagh et al., 2001b).
We observed that m04 is one of the most abundantly 
produced proteins of MCMV (unpublished data). Further-
more, a great number of polymorphic variants of m04 have 
been identified from MCMV strains isolated from wild mice, 
suggesting strong selective pressure (Smith et al., 2006). m04 
in complex with H-2Dk molecules is essential for the recog-
nition of infected cells by the activating Ly49P receptor 
(Kielczewska et al., 2009). m157, an MCMV glycoprotein 
recognized by the activating Ly49H and inhibitory Ly49I 
receptors, is also under intense selective pressure and easily 
mutated (Voigt et al., 2003; French et al., 2004). We propose 
that m04 originally evolved to function as an agonist of cer-
tain inhibitory Ly49 receptors and that the genesis of the ac-
tivating Ly49P receptor recognizing m04 was a consequence 
of counteracting selective pressure in the host.
Figure 6. Control of m04 MCMV is partially mediated via 
NKG2D. The indicated strains of mice were i.v. injected with 2 × 105 PFU 
of WT or m04 MCMV and 3 dpi viral loads in spleen were assessed. Mice 
were either untreated or NKG2D blockade was performed 6 h before in-
fection by applying 300 µg of anti-NKG2D mAb. P values, unpaired two-
tailed Mann-Whitney test. A circle depicts the titer for each individual 
mouse; the horizontal line indicates the mean. Data are representative of 
two independent experiments with five mice per group.
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supports this hypothesis. And yet, in our experiments shown 
in Fig. 3 (A and B), we observed that the impact of the ab-
sence of m04 was less dramatic in cells of H-2d background, 
both for Ly49A and Ly49C reporter cells, which could indi-
cate the presence of residual Ly49 inhibition in H2d mice. 
Also, the fact that Ly49G2 possesses two H-2d ligands, H-2D 
and H-2L, in BALB/c mice but only one, H-2D, in BALB.K 
or C3H/J, would further contribute to an increased threshold 
of activation in H-2d mice infected with m04 MCMV.
Together, our findings highlight the importance of viral 
modulation of MHC I to prevent missing self signals from 
being detected by NK cells. This study presents the first evi-
dence that NK cell recognition of the missing self is operational 
in the recognition and control of a viral pathogen in vivo.
MATERIALS AND METHODS
Mice and infection conditions. Mice used in experiments were housed 
and bred under SPF conditions. All the protocols used for the breeding of 
mice and different kinds of treatment were approved by the Ethical Com-
mittee of the University of Rijeka and were performed in accordance with 
Croatian Law for the Protection of Laboratory Animals that has been harmo-
nized with the existing EU legislation (EC Directive 86/609 EEC). Infec-
tions were performed by intravenous injection of the virus and, where 
indicated, NK cells were depleted by intraperitoneal injection of 20 µl of 
rabbit anti-asialo GM1 (Wako Chemicals) 24 h before infection. NKG2D 
blockade was performed by injection of 300 µg of anti-NKG2D antibody 
(C7 clone; Ho et al., 2002). Ly49 subsets were depleted by injections of 150 
µg of YE1/48 (anti-Ly49A), 5E6 (anti-Ly49C and Ly49I), or 4D11 (anti-
Ly49G2) antibodies (5E6 and 4D11 mAbs were a gift from W. Held, Lud-
wig Institute for Cancer Research Ltd., Lausanne Branch, Epalinges, 
Switzerland; Sentman et al., 1989; Takei, 1983; Mason et al., 1995). The 
viral titers in organs were quantified by the standard plaque assay.
Construction of chimeric Ly49 receptors. The full-length cDNA of 
Ly49aBALB was cloned into the pGEM-Teasy vector (Promega). Ly49cC57BL/6 
was a gift from F. Takei (University of British Columbia, Vancouver, Canada) 
and Ly49aC57BL/6 was a gift from J.R. Carlyle (University of Toronto, Ontario, 
Canada). CD3-NKR-P1A construct was a gift from W.M. Yokoyama (Wash-
ington University School of Medicine, St. Louis, MO). The construction of 
Ly49A-CD3 chimera was performed by PCR amplification of the CD3 in-
tracellular domain and Ly49A CTLD-Stalk domain with Esp3I designed restric-
tion sites at 5 and 3, respectively, subsequent Esp3I digestion and ligation (MBI 
Fermentas) such that the ligation site resided in the transmembrane region. The 
generation of the chimeric proteins of inhibitory Ly49 CTLD with an activating 
Ly49H backbone was performed as described in the paper by Kielczewska et al. 
(2007). In brief, the C-terminal CTLD domain of the inhibitory Ly49 receptors 
was amplified by PCR and fused via an Esp3I (MBI Fermentas) restriction site 
to the stalk, transmembrane region, and intracellular domain of the activating 
Ly49H. The chimeric receptor obtained with this approach acquires the ability 
to transmit activating signals upon ligation via the adapter protein DAP12. All 
cDNAs encoding the chimeric Ly49 receptors were subcloned into BamHI and 
NotI sites in the retroviral expression pMx-puro vector.
Reporter cell assay. 2B4 NFAT-GFP reporter cells were generated by 
retroviral transduction, as previously described (Arase et al., 2002). Primary 
CBA/J, BALB/c, BALB.K, BALB.F, and C57BL/6 MEFs were prepared by 
using a standard procedure (Brune et al., 1999). For the reporter cell assay, 
stimulator cells were infected (1.5 PFU/cell) with MCMV or MCMV 
deletion mutants (Wagner et al., 2002) for 12 h before the addition of re-
porter cells. NFAT-GFP reporter cells were co-cultured for 24 h with stim-
ulators in 24-well plates at a ratio of 1:3 and analyzed by flow cytometry.
contribute moderately to the control of the virus. In mice 
expressing H-2b, Ly49A lacks a ligand. In mice of the H-2k 
or H-2d background, Ly49A recognizes H-2Dk or H-2Dd, 
respectively (Karlhofer et al., 1992). Our present studies using 
Ly49A reporter cells suggest more efficient recognition of 
H-2k rather than H-2d, a difference that is augmented by the 
presence of m04. As such, the absence of m04 should have 
greatest impact in mice expressing H-2k, intermediate impact 
in mice expressing H-2d, and no effect in mice bearing H-2b, 
as supported by both our in vivo and in vitro results. Further-
more, it has been shown that Ly49A+ NK cells are unable to 
reject H-2b bone marrow grafts, but they act synergistically 
with Ly49G2+ cells (Raziuddin et al., 2000).
Ly49C+ cells, on the other hand, represent almost 50% of 
the NK cell population in BALB/c mice, but contribute only 
moderately to the control of the virus. Ly49C is able to inter-
act with H-2Kb and H-2Db in the H-2b background and, 
with H-2Kd and H-2Dd in the H-2d background, but only 
with H-2Dk in the H-2k background (Brennan et al., 1996b). 
Therefore, in the absence of m04 and reduced MHC I ex-
pression, NK cells of H-2k mice should show the greatest re-
duction in the inhibitory threshold. It is well established that 
MCMV encodes many MHC I–like molecules that are ex-
pressed on the surface of infected cells, and one can speculate 
that ligation of Ly49C by these molecules possibly results in 
the inhibition of Ly49C+ NK cell subset.
Ly49G2+ NK cells might be more efficient in detecting 
missing self, but inhibitory signals mediated by these cells might 
be weaker, as the strength of their interaction with MHC I is 
inferior to Ly49A, Ly49C, or Ly49I (Hanke et al., 1999). The 
robust response of Ly49G2+ NK cells raises the possibility of 
the existence of an activating receptor that is preferentially co-
expressed on these cells and drives their proliferation. Because 
a preferential coexpression of Ly49D and Ly49H activation 
receptors has been shown (Smith et al., 2000), we cannot 
exclude the possible coexpression of an MCMV-specific acti-
vating receptor on these NK cells. We showed that NKG2D 
receptor blocking resulted in a significant increase in the m04 
virus titer, although it did not completely eliminate NK cell–
mediated resistance by itself, suggesting the involvement of 
other activating NK cell receptors.
It has been shown that Ly49A+ NK cell subsets are only 
weakly licensed in C57BL/6 mice (Brodin et al., 2009; Jonsson 
et al., 2010), which in the absence of an H-2b ligand is also 
expected for Ly49G2+ NK cells. Therefore, these cells are 
probably not operational in the missing self–mediated recog-
nition of virally infected cells and this might be the reason 
why we have not observed the phenotype of m04 mutant in 
C57BL/6 mice. The quantitative differences of the m04 effect 
between H-2k and H-2d mice are not easy to explain in the 
absence of detailed knowledge of the binding of MHC I mol-
ecules for their cognate receptors. However, several nonex-
clusive mechanisms could be at play, including quantitative 
differences in the strength of licensing. A recent study by 
Jonsson et al. (2010) showing better licensing of Ly49A+ NK 
cells in mice of the H-2k compared with the H-2d haplotype 
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